BioSpace News Archive

Business

PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today provided a corporate update and reported financial results for the three and nine months ended September 30, 2023.

November 8, 2023
·
11 min read
Heart Failure start-up, Acorai, secures €2.3m grant funding from the European Commission

Acorai, a start-up medical device manufacturer from Sweden, announces selection for a €2.3m grant with a follow-on €10m investment offer from the European Innovation Council.

November 8, 2023
·
3 min read
Business

CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA

CASI Pharmaceuticals Inc. is thrilled to announce a major milestone in its partnership with Juventas Cell Therapy Ltd. (Juventas).

November 8, 2023
·
7 min read
Silence Therapeutics to Present at Jefferies London Healthcare Conference - November 8, 2023

Silence Therapeutics plc today announced that Craig Tooman, Silence President and CEO, will present a corporate update at the Jefferies London Healthcare Conference on Wednesday, November 15th at 4:30 p.m. GMT.

November 8, 2023
·
1 min read
Pharm Country

Arbutus to Present at Jefferies London Healthcare Conference - November 8, 2023

Arbutus Biopharma Corporation today announced that the Arbutus management team will participate in and host one-on-one meetings at the following investor conference.

November 8, 2023
·
1 min read
Business

Akebia Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today reported financial results for the third quarter ended September 30, 2023 and reviewed recent business highlights.

November 8, 2023
·
12 min read